1. Home
  2. FHN vs RGEN Comparison

FHN vs RGEN Comparison

Compare FHN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHN
  • RGEN
  • Stock Information
  • Founded
  • FHN 1864
  • RGEN 1981
  • Country
  • FHN United States
  • RGEN United States
  • Employees
  • FHN N/A
  • RGEN N/A
  • Industry
  • FHN Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • FHN Finance
  • RGEN Health Care
  • Exchange
  • FHN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • FHN 9.1B
  • RGEN 8.0B
  • IPO Year
  • FHN N/A
  • RGEN N/A
  • Fundamental
  • Price
  • FHN $22.01
  • RGEN $127.47
  • Analyst Decision
  • FHN Buy
  • RGEN Buy
  • Analyst Count
  • FHN 17
  • RGEN 12
  • Target Price
  • FHN $22.26
  • RGEN $170.40
  • AVG Volume (30 Days)
  • FHN 5.9M
  • RGEN 685.0K
  • Earning Date
  • FHN 07-16-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • FHN 2.76%
  • RGEN N/A
  • EPS Growth
  • FHN N/A
  • RGEN N/A
  • EPS
  • FHN 1.44
  • RGEN N/A
  • Revenue
  • FHN $3,043,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • FHN $11.15
  • RGEN $13.93
  • Revenue Next Year
  • FHN $3.91
  • RGEN $14.35
  • P/E Ratio
  • FHN $15.30
  • RGEN N/A
  • Revenue Growth
  • FHN 3.43
  • RGEN 4.88
  • 52 Week Low
  • FHN $14.34
  • RGEN $102.97
  • 52 Week High
  • FHN $22.44
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • FHN 74.09
  • RGEN 54.11
  • Support Level
  • FHN $20.98
  • RGEN $121.44
  • Resistance Level
  • FHN $20.62
  • RGEN $131.43
  • Average True Range (ATR)
  • FHN 0.41
  • RGEN 4.47
  • MACD
  • FHN 0.19
  • RGEN 0.61
  • Stochastic Oscillator
  • FHN 95.35
  • RGEN 74.57

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: